Phase 1, pharmacokinetic (PK) and pharmacodynamic (PD) study of oral alvespimycin (A; KOS-1022; 17-DMAG): Two different schedules in patients with advanced malignanciesKeith T Flaherty, Lia Gore, A N Avadhani,Stephen Leong,Kathleen Harlacker,Z Zhong, R G Johnson,A L Hannah, Peter J Odwyer,S G Eckhardtmag（2007）引用 28|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
